Global End Stage Renal Disease Market Size To Exceed USD 348.4 Billion by 2033: Market Study Report

Global End Stage Renal Disease Market Size To Exceed USD 348.4 Billion by 2033

According to a research report published by Spherical Insights & Consulting, The Global End Stage Renal Disease Market Size is Expected to Grow from USD 111.1 Billion in 2023 to USD 348.4 Billion by 2033, at a CAGR of 12.11% during the forecast period 2023-2033.          

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global End Stage Renal Disease Market Size, Share, and COVID-19 Impact Analysis, By Treatment (Transplant and Dialysis [Peritoneal Dialysis, Hemodialysis, and Wearable Artificial Kidney]), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

The end-stage renal disease (ESRD) market refers to the global industry focused on the diagnosis, treatment, and management of end-stage renal disease—a severe, irreversible stage of chronic kidney disease (CKD) where kidney function is nearly or completely lost. This market includes dialysis services, kidney transplantation, pharmaceuticals, medical devices, and supportive therapies aimed at managing ESRD and improving patient outcomes. Furthermore, the worldwide end-stage renal disease (ESRD) market is fueled by the increasing incidence of chronic kidney disease, growing instances of diabetes and hypertension, technological developments in dialysis and transplantation technologies, and expanding healthcare spending. Moreover, better accessibility to treatment, favorable reimbursement schemes, the growing population of geriatrics, and the growing awareness of kidney diseases drive the market. However, the high treatment costs, limited organ donors, dialysis-related complications, stringent regulations, low awareness, economic constraints in developing regions, and dependency on lifelong treatment are key restraints for the growth of the market.

The dialysis segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.             

On the basis of the treatment, the global end stage renal disease market is divided into transplant and dialysis. The dialysis segment is divided into peritoneal dialysis, hemodialysis, and wearable artificial kidney. Among these, the dialysis segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to the rising prevalence of end-stage renal disease, increasing geriatric population, and limited kidney transplant availability. Technological advancements, improved dialysis accessibility, government initiatives, and growing patient preference for home dialysis further drive its significant CAGR during the forecast period.

North America is projected to hold the largest share of the global end stage renal disease market over the forecast period.

North America is projected to hold the largest share of the global end stage renal disease market over the forecast period. The regional growth is attributed to its advanced healthcare infrastructure, high prevalence of kidney disease, and increasing geriatric population. Strong reimbursement policies, government support, rising adoption of dialysis and transplantation procedures, and the presence of key market players further contribute to the region’s substantial market share.

Asia Pacific is expected to grow at the fastest CAGR growth of the global end stage renal disease market during the forecast period. The regional growth is attributed to the rising prevalence of chronic kidney disease, the increasing aging population, and improving healthcare infrastructure. Growing awareness, expanding dialysis centers, government initiatives, and technological advancements in renal care further drive market growth. Additionally, economic development and increasing healthcare expenditure enhance treatment accessibility in the region.

Company Profiling

Major vendors in the global end stage renal disease market are Nipro Corp., Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., Medtronic Plc, B. Braun Melsungen AG, BD, Asahi Kasei Medical Co., Ltd., Cantel Medical, Nikkiso Co., Ltd., JMS Co. Ltd., and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global end stage renal disease market based on the below-mentioned segments: 

Global End Stage Renal Disease Market, By Treatment

• Transplant
• Dialysis
  • Peritoneal Dialysis
  • Hemodialysis
  • Wearable Artificial Kidney

Global End Stage Renal Disease Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa